. Author manuscript; available in PMC: 2011 Aug 1.

Published in final edited form as: Biochim Biophys Acta. 2010 May 21;1797(8):1555–1562. doi: 10.1016/j.bbabio.2010.05.007

Table 3.

Mitochondrial phospholipid fatty acid composition expressed as molar percent of total phospholipid fatty acid.

Fatty Acid	Control	DHA	EPA
C16:0	12.2 ± 0.8	13.3 ± 0.5	10.8 ± 0.6
C16:1	BQL	BQL	4.5 ± 1.8
C18:0	20.0 ± 0.4	18.9 ± 0.5	19.8 ± 0.8
C18:1n9	14.3 ± 0.8	13.0 ± 1.0	11.8 ± 1.0
C18:1n7	4.5 ± 0.2	3.7 ± 0.2 ^*	4.2 ± 0.2
C18:2n6	22.0 ± 0.9	23.1 ± 1.0	22.4 ± 0.8
C20:3n6	BQL	1.6 ± 0.2 ^*	1.1 ± 0.2 ^*
C20:4n6	14.6 ± 1.0	5.7 ± 0.2 ^*	9.8 ± 0.8 ^*^#
C20:5n3	BQL	4.4 ± 0.3 ^*	6.0 ± 0.2 ^*
C22:6n3	9.1 ± 0.5	14.8 ± 0.6 ^*	8.3 ± 0.2 ^#
Total ω-3 PUFA	9.1 ± 0.5	19.2 ± 0.5 ^*	14.3 ± 0.3 ^*^#

Data are expressed as percent of total mitochondrial membrane phospholipid content. BQL, below the quantifiable limit (limit of detection = 0.41% of total phospholipid fatty acids). Data are the mean ± SEM. n = 7–8/group.

p < 0.05 compared to the control group;

p < 0.001 compared to DHA